DK2240578T3 - I alt væsentligt dyreproteinfrit rekombinant furin og fremgangsmåder til fremstilling af samme - Google Patents

I alt væsentligt dyreproteinfrit rekombinant furin og fremgangsmåder til fremstilling af samme Download PDF

Info

Publication number
DK2240578T3
DK2240578T3 DK08869658.8T DK08869658T DK2240578T3 DK 2240578 T3 DK2240578 T3 DK 2240578T3 DK 08869658 T DK08869658 T DK 08869658T DK 2240578 T3 DK2240578 T3 DK 2240578T3
Authority
DK
Denmark
Prior art keywords
manufacture
methods
free recombinant
recombinant furin
deposit free
Prior art date
Application number
DK08869658.8T
Other languages
Danish (da)
English (en)
Inventor
Roland Geyer
Artur Mitterer
Manfred Reiter
Meinhard Hasslacher
Barbara Plaimauer
Fircks Simone Von
Leopold Grillberger
Original Assignee
Baxalta GmbH
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40524590&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2240578(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta GmbH, Baxalta Inc filed Critical Baxalta GmbH
Application granted granted Critical
Publication of DK2240578T3 publication Critical patent/DK2240578T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6454Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08869658.8T 2007-12-31 2008-12-19 I alt væsentligt dyreproteinfrit rekombinant furin og fremgangsmåder til fremstilling af samme DK2240578T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1815207P 2007-12-31 2007-12-31
PCT/US2008/087732 WO2009088713A1 (en) 2007-12-31 2008-12-19 Substantially animal protein-free recombinant furin and methods for producing same

Publications (1)

Publication Number Publication Date
DK2240578T3 true DK2240578T3 (da) 2019-06-17

Family

ID=40524590

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08869658.8T DK2240578T3 (da) 2007-12-31 2008-12-19 I alt væsentligt dyreproteinfrit rekombinant furin og fremgangsmåder til fremstilling af samme

Country Status (18)

Country Link
US (2) US20090181423A1 (pt)
EP (2) EP2240578B1 (pt)
JP (2) JP5806465B2 (pt)
KR (1) KR101618144B1 (pt)
CN (2) CN101910401A (pt)
AR (2) AR069892A1 (pt)
AU (1) AU2008346817B2 (pt)
BR (1) BRPI0821467B8 (pt)
CA (1) CA2710260C (pt)
DK (1) DK2240578T3 (pt)
ES (2) ES2735173T3 (pt)
HU (1) HUE043863T2 (pt)
MX (1) MX2010007344A (pt)
NZ (1) NZ586411A (pt)
PL (2) PL3521422T3 (pt)
PT (1) PT2240578T (pt)
SG (2) SG10201805749QA (pt)
WO (1) WO2009088713A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147097A2 (en) * 2007-05-22 2010-01-27 Baxter Int PREPARATIVE PURIFICATION METHOD FOR HUMAN FURINE
SG10201805749QA (en) 2007-12-31 2018-08-30 Baxalta Inc Substantially animal protein-free recombinant furin and methods for producing same
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
ES2761692T5 (es) 2010-07-08 2023-07-05 Takeda Pharmaceuticals Co Método de producción de vWF recombinante de alto peso molecular en cultivo celular
US20140051832A1 (en) * 2011-03-11 2014-02-20 Universidade De São Paulo - Usp Method for the production of recombinant human factor viii
CN103889454B (zh) * 2011-06-02 2017-04-05 百深有限责任公司 重组成对碱性氨基酸蛋白酶的制剂
AR102048A1 (es) * 2014-08-12 2017-02-01 Baxalta Inc Producción del factor x completamente procesado y funcional en un sistema de expresión de mamífero de secreción de furina
KR102568951B1 (ko) 2014-12-22 2023-08-22 젠자임 코포레이션 포유류 세포의 배양 방법
WO2018234543A1 (en) * 2017-06-23 2018-12-27 Baxalta Incorporated PURIFICATION OF FACTOR VIII SUBSPECIES

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815207A (en) 1929-01-18 1931-07-21 John H Moffat Vehicle parking and locking device
NL9000917A (nl) 1989-10-25 1991-05-16 Holland Biotechnology Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.
EP0785273A1 (en) 1990-11-26 1997-07-23 Genetics Institute, Inc. Paired basic amino acid converting enzyme and DNA sequence encoding it
US5604201A (en) * 1993-01-08 1997-02-18 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization Methods and reagents for inhibiting furin endoprotease
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
EP1983044B1 (en) 1996-10-10 2016-08-10 Life Technologies Corporation Animal cell culture media comprising plant-derived nutrients
AT407750B (de) 1999-02-19 2001-05-25 Immuno Ag Verfahren zur herstellung einer vwf-präparation
US6596526B1 (en) * 2000-06-09 2003-07-22 Baxter Aktiengesellschaft Furin polypeptides with improved characteristics
SE0103084D0 (sv) * 2001-09-14 2001-09-14 Amersham Pharm Biotech Ab Generation of ion exchange media
US20030091976A1 (en) 2001-11-14 2003-05-15 Ciphergen Biosystems, Inc. Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
ES2398706T3 (es) * 2002-07-09 2013-03-21 Baxter International Inc. Medio exento de proteínas animales para el cultivo de células
AU2005216847B2 (en) * 2004-02-27 2010-04-01 Cytiva Bioprocess R&D Ab A process for the purification of antibodies
ES2474573T3 (es) * 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
EP2147097A2 (en) 2007-05-22 2010-01-27 Baxter Int PREPARATIVE PURIFICATION METHOD FOR HUMAN FURINE
SG10201805749QA (en) 2007-12-31 2018-08-30 Baxalta Inc Substantially animal protein-free recombinant furin and methods for producing same
US9718255B2 (en) 2011-11-03 2017-08-01 Barson Composites Corporation Corrosion-resistant diffusion coatings

Also Published As

Publication number Publication date
BRPI0821467B1 (pt) 2019-10-15
CN110066782A (zh) 2019-07-30
KR101618144B1 (ko) 2016-05-17
JP2015154790A (ja) 2015-08-27
CN110066782B (zh) 2024-04-16
EP2240578B1 (en) 2019-03-20
AU2008346817A1 (en) 2009-07-16
US9127264B2 (en) 2015-09-08
EP2240578A1 (en) 2010-10-20
PT2240578T (pt) 2019-06-19
SG10201805749QA (en) 2018-08-30
US20110076719A1 (en) 2011-03-31
EP3521422A1 (en) 2019-08-07
JP2011507550A (ja) 2011-03-10
CA2710260A1 (en) 2009-07-16
CN101910401A (zh) 2010-12-08
US20090181423A1 (en) 2009-07-16
AR113492A2 (es) 2020-05-06
BRPI0821467B8 (pt) 2021-05-25
BRPI0821467A2 (pt) 2014-10-14
SG192471A1 (en) 2013-08-30
AR069892A1 (es) 2010-02-24
MX2010007344A (es) 2010-11-09
KR20100114057A (ko) 2010-10-22
JP5806465B2 (ja) 2015-11-10
WO2009088713A1 (en) 2009-07-16
AU2008346817B2 (en) 2014-07-24
HUE043863T2 (hu) 2019-09-30
EP3521422B1 (en) 2021-10-06
PL2240578T3 (pl) 2019-09-30
ES2735173T3 (es) 2019-12-16
NZ586411A (en) 2012-06-29
ES2897561T3 (es) 2022-03-01
PL3521422T3 (pl) 2021-12-20
CA2710260C (en) 2023-07-11

Similar Documents

Publication Publication Date Title
DK2240578T3 (da) I alt væsentligt dyreproteinfrit rekombinant furin og fremgangsmåder til fremstilling af samme
DK3150240T3 (da) Systemer og fremgangsmåder til fremføring af terapeutiske midler
DK2676967T3 (da) Fremgangsmåder til behandling af inflammatoriske og autoimmune sygdomme med natalizumab
DK2494039T3 (da) Fremgangsmåder til reprogrammering af celler og anvendelser deraf
DK2638149T3 (da) Immortalisering af epitelceller og fremgangsmåder til anvendelse
DK2417308T3 (da) Bygning og fremgangsmåde til opførelse af en bygning
DK2470656T3 (da) Sammensætning til hæmning af genekspression og anvendelser heraf
DE602006008357D1 (de) Umsetzung von zeit in digital mit verzögerungsbeitragsbestimmung von verzögerungselementen
DK1996292T3 (da) Anvendelse af peptider til bekæmpelse af stråleskade
DK3012329T3 (da) Fremgangsmåder og materialer til at vurdere tab af heterozygositet
DK2565193T3 (da) Sammensætninger og fremgangsmåder til hæmning af JAK-signalvejen
DK2598483T3 (da) Ampk-aktiverende heterocykliske forbindelser og fremgangsmåder til anvendelse af disse
DK2464773T3 (da) Fremgangsmåde til binding af glasfiber og glasfiberprodukt
DK2154302T3 (da) Fleksibel plade af mursten til konstruktion af arkitektoniske elementer, og fremgangsmåde til fremstilling af pladen
DK2913344T3 (da) Specifikke bindingsproteiner og anvendelser deraf
DK3168229T3 (da) Fremstilling af proteiner og polypeptider.
DK2513193T3 (da) Forbedrede blends af polyarylenethere og polyarylensulfider
DK2446246T3 (da) Indretning og fremgangsmåde til udvælgelse af partikler
DK2445912T3 (da) Ny forbindelse anvendelig til behandlingen af degenerative og inflammatoriske sygdomme
DK2361090T3 (da) Sammensætninger til behandling af centralt medieret kvalme og opkastning
DK2222314T3 (da) Anvendelser og midler til opnåelse af bronchorelaxation
DK2346765T3 (da) Indretning og fremgangsmåde til samling af flade genstande
FR2945298B1 (fr) Pont temporaire perfectionne
DK2647068T3 (da) Batterielektrode og metode til fremstilling af samme
DK2555789T3 (da) Hæmmende peptider afledt af trem-lignende transcript 1 (tlt-1) og anvendelser deraf